1981
DOI: 10.1002/1097-0142(19810115)47:2<410::aid-cncr2820470232>3.0.co;2-d
|View full text |Cite
|
Sign up to set email alerts
|

Acinar cell cystadenocarcinoma of human pancreas

Abstract: A 7000 g cystic tumor replacing the body and tail of the pancreas was resected in a 64-year-old man. Numerous peritoneal implants confirmed its malignant nature. Light microscopy of both the primary tumor and the implants revealed distinctive cytoplasmic eosinophilia and apical granules. Ultrastructural examination demonstrated numerous zymogen granules and abundant, rough endoplasmic reticulum, which confirmed that the tumor was composed of acinar cells. No mucinous or serous differentiation was detected. We … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
25
0

Year Published

1984
1984
2007
2007

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 88 publications
(25 citation statements)
references
References 11 publications
0
25
0
Order By: Relevance
“…An important step forward was the differentiation of serous cystic from MCNs by Compagno and Oertel [12] and Hodgkinson et al [19]. Then followed the descriptions of the cystic variants of acinar cell carcinoma [10,20,56] and the cystic (ductectatic), mucin-producing, intraductal neoplasms [47,49,52] that were finally termed intraductal papillary-mucinous tumors [21,28,39,54] and clearly distinguished from MCNs [55,63]. Recently, the IPMNs have been subdivided into an intestinal, MUC2-positive type [which appears to be the precursor of mucinous noncystic (colloid) carcinoma] [42], a pancreatobiliary, MUC1-positive type and an oncocytic type [3].…”
Section: Discussionmentioning
confidence: 99%
“…An important step forward was the differentiation of serous cystic from MCNs by Compagno and Oertel [12] and Hodgkinson et al [19]. Then followed the descriptions of the cystic variants of acinar cell carcinoma [10,20,56] and the cystic (ductectatic), mucin-producing, intraductal neoplasms [47,49,52] that were finally termed intraductal papillary-mucinous tumors [21,28,39,54] and clearly distinguished from MCNs [55,63]. Recently, the IPMNs have been subdivided into an intestinal, MUC2-positive type [which appears to be the precursor of mucinous noncystic (colloid) carcinoma] [42], a pancreatobiliary, MUC1-positive type and an oncocytic type [3].…”
Section: Discussionmentioning
confidence: 99%
“…A rare variant of acinar cell carcinoma (acinar cell cystadenocarcinoma) is composed of innumerable variably-sized cysts, each lined by neoplastic acinar cells. 98,[110][111][112] Zymogen granules are positive for periodic acidSchiff (PAS), resistant to diastase digestion (dPAS) in 95% of acinar cell carcinomas. In cases with typical histologic features, the finding of granular dPAS positivity in the apical cytoplasm may be sufficient to confirm the diagnosis; however, many acinar cell carcinomas do not contain sufficient quantities of zymogen granules for this stain to provide convincing results, and immunohistochemical staining is a much more specific and sensitive technique.…”
Section: Acinar Cell Carcinoma and Mixed Acinar Carcinomasmentioning
confidence: 99%
“…The most common cystic tumors are intraductal papillary-mucinous neoplasms, serous cystic neoplasms, mucinous cystic neoplasms and solid pseudopapillary neoplasms. 2,3 Rare cystic neoplasms include acinar cell cystadenocarcinomas, 4 acinar cell cystadenomas, 5 cystic endocrine tumors 6 and cystic mesenchymal tumors. 7 The differential diagnosis of pancreatic cystic neoplasms, however, also includes pancreatic ductal adenocarcinomas with cystic changes.…”
mentioning
confidence: 99%